vs
Side-by-side financial comparison of DNA X, Inc. (SONM) and SWK Holdings Corp (SWKH). Click either name above to swap in a different company.
DNA X, Inc. is the larger business by last-quarter revenue ($16.2M vs $8.7M, roughly 1.9× SWK Holdings Corp). On growth, DNA X, Inc. posted the faster year-over-year revenue change (7.9% vs -29.7%). Over the past eight quarters, DNA X, Inc.'s revenue compounded faster (9.9% CAGR vs -12.5%).
SWK Holdings Corp is a specialty finance firm focused on the healthcare and life sciences sectors. It provides tailored financing solutions including royalty monetization, structured debt, and asset-backed lending to biotech, pharmaceutical, medical device and diagnostic companies, with its core market centered in North America.
SONM vs SWKH — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $16.2M | $8.7M |
| Net Profit | $-4.8M | $-19.4M |
| Gross Margin | 11.2% | — |
| Operating Margin | -24.5% | 9.9% |
| Net Margin | -29.3% | — |
| Revenue YoY | 7.9% | -29.7% |
| Net Profit YoY | -89.2% | -430.2% |
| EPS (diluted) | $-4.83 | $-1.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $8.7M | ||
| Q3 25 | $16.2M | $10.9M | ||
| Q2 25 | $11.2M | $10.1M | ||
| Q1 25 | $16.7M | $11.8M | ||
| Q4 24 | $15.3M | $12.4M | ||
| Q3 24 | $15.0M | $10.4M | ||
| Q2 24 | $11.5M | $10.8M | ||
| Q1 24 | $9.1M | $11.4M |
| Q4 25 | — | $-19.4M | ||
| Q3 25 | $-4.8M | $8.8M | ||
| Q2 25 | $-7.5M | $3.5M | ||
| Q1 25 | $458.0K | $4.5M | ||
| Q4 24 | $-21.6M | $5.9M | ||
| Q3 24 | $-2.5M | $3.5M | ||
| Q2 24 | $-6.6M | $3.7M | ||
| Q1 24 | $-2.9M | $468.0K |
| Q4 25 | — | — | ||
| Q3 25 | 11.2% | — | ||
| Q2 25 | 7.6% | — | ||
| Q1 25 | 50.0% | — | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 28.2% | — | ||
| Q2 24 | 25.8% | — | ||
| Q1 24 | 31.8% | — |
| Q4 25 | — | 9.9% | ||
| Q3 25 | -24.5% | 61.3% | ||
| Q2 25 | -60.2% | 46.1% | ||
| Q1 25 | 3.9% | 68.6% | ||
| Q4 24 | 55.3% | 44.7% | ||
| Q3 24 | -15.8% | 39.2% | ||
| Q2 24 | -56.2% | 8.3% | ||
| Q1 24 | -29.5% | 9.5% |
| Q4 25 | — | — | ||
| Q3 25 | -29.3% | 80.7% | ||
| Q2 25 | -66.8% | 35.2% | ||
| Q1 25 | 2.7% | 38.4% | ||
| Q4 24 | -141.6% | 47.5% | ||
| Q3 24 | -16.7% | 33.3% | ||
| Q2 24 | -57.5% | 33.9% | ||
| Q1 24 | -31.9% | 4.1% |
| Q4 25 | — | $-1.59 | ||
| Q3 25 | $-4.83 | $0.72 | ||
| Q2 25 | $-0.79 | $0.29 | ||
| Q1 25 | $0.08 | $0.37 | ||
| Q4 24 | $-116.99 | $0.47 | ||
| Q3 24 | $-9.32 | $0.28 | ||
| Q2 24 | $-1.41 | $0.30 | ||
| Q1 24 | $-0.65 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.1M | $42.8M |
| Total DebtLower is stronger | $5.1M | $33.0M |
| Stockholders' EquityBook value | $-701.0K | $235.1M |
| Total Assets | $40.2M | $272.4M |
| Debt / EquityLower = less leverage | — | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $42.8M | ||
| Q3 25 | $2.1M | $10.2M | ||
| Q2 25 | $2.0M | $8.0M | ||
| Q1 25 | $2.1M | $29.8M | ||
| Q4 24 | $5.3M | $5.9M | ||
| Q3 24 | $9.1M | $17.2M | ||
| Q2 24 | $9.6M | $5.5M | ||
| Q1 24 | $9.3M | $5.5M |
| Q4 25 | — | $33.0M | ||
| Q3 25 | $5.1M | $33.0M | ||
| Q2 25 | $2.9M | $33.0M | ||
| Q1 25 | $2.8M | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $33.0M |
| Q4 25 | — | $235.1M | ||
| Q3 25 | $-701.0K | $254.2M | ||
| Q2 25 | $-1.3M | $246.5M | ||
| Q1 25 | $-1.1M | $292.7M | ||
| Q4 24 | $-5.7M | $288.7M | ||
| Q3 24 | $15.3M | $283.4M | ||
| Q2 24 | $17.5M | $282.8M | ||
| Q1 24 | $19.8M | $279.9M |
| Q4 25 | — | $272.4M | ||
| Q3 25 | $40.2M | $289.4M | ||
| Q2 25 | $36.1M | $285.7M | ||
| Q1 25 | $36.0M | $331.3M | ||
| Q4 24 | $39.7M | $332.2M | ||
| Q3 24 | $49.1M | $321.3M | ||
| Q2 24 | $45.9M | $321.0M | ||
| Q1 24 | $42.4M | $322.0M |
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.0M | $27.3M |
| Free Cash FlowOCF − Capex | — | $26.8M |
| FCF MarginFCF / Revenue | — | 308.1% |
| Capex IntensityCapex / Revenue | — | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $43.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $27.3M | ||
| Q3 25 | $-7.0M | $906.0K | ||
| Q2 25 | $-4.9M | $7.8M | ||
| Q1 25 | $-9.6M | $8.3M | ||
| Q4 24 | $-4.5M | $23.0M | ||
| Q3 24 | $-417.0K | $6.3M | ||
| Q2 24 | $-3.4M | $5.4M | ||
| Q1 24 | $-168.0K | $4.4M |
| Q4 25 | — | $26.8M | ||
| Q3 25 | — | $557.0K | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | — | $8.2M | ||
| Q4 24 | $-4.5M | $22.9M | ||
| Q3 24 | $-554.0K | $6.3M | ||
| Q2 24 | $-3.4M | $5.4M | ||
| Q1 24 | $-198.0K | — |
| Q4 25 | — | 308.1% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 77.0% | ||
| Q1 25 | — | 69.1% | ||
| Q4 24 | -29.6% | 185.3% | ||
| Q3 24 | -3.7% | 60.4% | ||
| Q2 24 | -29.8% | 49.7% | ||
| Q1 24 | -2.2% | — |
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | 0.1% | 1.1% | ||
| Q3 24 | 0.9% | 0.3% | ||
| Q2 24 | 0.3% | 0.2% | ||
| Q1 24 | 0.3% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | -20.97× | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SONM
Segment breakdown not available.
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
